Anduril Raises $5B at $61B Valuation; Funds Barracuda-500M Production Ramp
The timing matters. Anduril raised this capital after the Army contract was public, meaning Andreessen Horowitz and Thrive Capital are pricing the company with full visibility to a $1B+ revenue stream over three years (10,000 missiles at $100K-150K unit cost, estimated). This is different from a speculative round on autonomous systems potential — it's capital deployment behind a proven procurement.
If Anduril can achieve 30-40% EBITDA margins on Barracuda production (typical for low-cost munitions), the company reaches profitability within 24 months, which reshapes the venture-to-defense-prime trajectory that RTX, Northrop, and Lockheed have dominated.
Anduril now has explicit capital to execute the Barracuda production commitment without diluting equity or seeking additional rounds through FY28.
The $5B raise removes the funding constraint that would otherwise force Anduril to choose between scaling the Barracuda line or investing in autonomous systems development — the two stated priorities.
Watch whether Anduril commits to a specific Barracuda production ramp rate (units per quarter) in the next earnings or investor briefing, which will signal whether the $5B is sufficient to meet the Army's three-year 10,000-unit cadence or whether additional capital will be needed by late 2027.
Does the $5B allocation split between Barracuda production capacity and autonomous systems R&D, or is the entire raise earmarked for manufacturing? The article doesn't specify.
Fault Lines
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.